Browsing Tag
NSE
162 posts
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Granules India (NSE: GRANULES) exits FDA audit with four observations as regulatory scrutiny intensifies
Granules India's Chantilly facility exits a routine US FDA cGMP audit with four procedural Form 483 observations and no data integrity findings. Read what it means for the GRANULES growth outlook.
K.P. Energy (KPEL) signs IPL deal with Delhi Capitals as stock trades 50% below 52-week high
KP Group's three listed companies join Delhi Capitals as IPL associate sponsors for 2026-2028. What does the strategy mean for KPEL and KPIGREEN? Read more.
Eternal (NSE: ETERNAL): Can Blinkit carry the whole company into profit?
Eternal (NSE: ETERNAL) is trading 37% off its October peak. Blinkit just hit EBITDA breakeven. Here is what retail investors need to watch before Q4 FY26 results.
Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)
Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.
Titan Company (NSE: TITAN) after a record FY26: The bull case, the risks and what comes next
Titan Company (NSE: TITAN) Q4 FY26 jewellery sales up 57.6%. Full-year results due. CLSA target Rs 4,996, UBS Rs 5,300. Risks and outlook for retail investors.
Dev Information Technology (NSE: DEVIT) to offload ByteSIGNER and Talligence as XDuce partnership reshapes strategic direction
Dev Information Technology transfers ByteSIGNER and Talligence to an associate for Rs 11.90 crore as XDuce's 24% stake signals a bold services-only pivot. Read the full analysis.
Saharsh Davuluri takes helm at Neuland Laboratories as CDMO accelerates push into commercial NCE contracts
Saharsh Davuluri takes over as CEO of Neuland Laboratories, steering the Indian CDMO into an aggressive peptide and NCE expansion. Read what this means for investors and competitors.
Rain Industries (NSE: RAIN) and Green Graphite Technologies complete graphite purification project as Ontario eyes domestic battery supply chain independence
Rain Industries unit Rain Carbon Canada completes battery graphite pilot with Green Graphite Technologies. What it means for RAIN stock. Read the full analysis.
PhysicsWallah (NSE: PWL) kicks off FY27 academic cycle with Rs 205cr Vishwas Diwas collections, posting 36% year-on-year growth
PhysicsWallah reports Rs 205 crore Vishwas Diwas collections, 36% YoY growth, 439K enrollments. What it means for PWL stock and India edtech. Read more.